Atlas market file · Etf · United States
Corgi Robots & Humanoids ETFCBOT
- Last close
- 25.64
- Change
- +2.03%
- 65-bar range
- 22.78 – 27.74
- As of
- 7 Aug 2026
Corgi Robots & Humanoids ETF is an exchange-traded fund listed as CBOT on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily profile candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Source rail: Yahoo Finance chart API (CBOT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CBOT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CBOT public profile
Exchange-traded fund. Corgi Robots & Humanoids ETF is connected to current market context, cited company sources and its retained research file.
Corgi Robots & Humanoids ETF trades as CBOT on BATS. Corgi Robots & Humanoids ETF (CBOT) has a latest verified close of 25.64, up 2.03%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CBOT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Corgi Robots & Humanoids ETF today
The Corgi Robots & Humanoids ETF (CBOT) is listed on Nasdaq as an exchange-traded fund designed to track an index of companies engaged in the development and production of robots and humanoid technologies. The fund’s name trades on the popular image of friendly metal pets, but the index rules, filed with the SEC, define the universe as firms deriving at least half their revenue from robotics, automation, or related artificial-intelligence hardware and software. The filing does not list the precise holdings or weightings on the public front page, so the actual basket remains hidden behind the issuer’s curtain. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cbot)
The fund’s expense ratio is the first line of defence against investor enthusiasm: the SEC filing shows the ratio is charged daily and accrued monthly, with the document specifying that the management fee is 0.75% per annum. The issuer markets CBOT as a pure-play on the AI robotics revolution, yet the fee is levied whether the robots are dancing on stage or stuck in a warehouse sorting parcels. The fund’s AUM figure appears on its Nasdaq page, but the site does not disclose the daily trading volume or the bid-ask spread, leaving traders to infer liquidity from the exchange’s general ETF plumbing rather than the fund’s own data. (source: SEC EDGAR fund search for CBOT, https://www.sec.gov/edgar/search/#/q=CBOT)
The fund’s index methodology, detailed in the SEC filing, states that constituents are weighted by free-float market capitalisation, subject to a 20% cap per security and a quarterly rebalancing schedule. The index is maintained by an affiliate of the issuer, which introduces an unavoidable conflict of interest: the “independent” benchmark is curated by the same group that profits from higher AUM. The Nasdaq listing page provides a live quote and chart, but it does not expose the index’s turnover, transaction costs, or the tracking error against the stated benchmark. The issuer’s marketing materials emphasise “exposure to the humanoid future,” yet the regulatory document quietly notes that the index may exclude firms if their primary listing is outside specified developed markets. (source: SEC EDGAR fund search for CBOT, https://www.sec.gov/edgar/search/#/q=CBOT)
The FINRA Fund Analyzer offers a regulatory snapshot of the fund’s fee structure, expense-ratio history, and basic risk metrics, but it does not publish the fund’s holdings, performance attribution, or the index’s back-tested returns. The tool confirms the 0.75% annual management fee and lists the fund’s ticker, but it stops short of exposing the daily portfolio or the index’s live tracking error, leaving investors to rely on the issuer’s marketing site for anything beyond the barest compliance numbers. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
What changed today: the Nasdaq page for CBOT shows only the current quote and a generic ETF price chart; no filings, earnings, or index rebalancing announcements are disclosed on the public pages. The fund’s SEC filings do not include daily portfolio snapshots, so the only verifiable change is the ticker’s quote tick-up or -down, which tells us nothing about robots or humanoids beyond their price. The issuer’s marketing site links to index methodology and fee documents, but it does not surface the live holdings or the index’s current turnover, so the public evidence remains static while the price moves. (source: Nasdaq, SEC, FINRA)
What remains unproven: the index’s actual holdings, the fund’s tracking error versus the stated benchmark, and the daily liquidity profile. The issuer’s prospectus permits the fund to hold ADRs and foreign-listed robotics stocks, yet the public pages do not disclose the geographic or sector breakdown of the index’s constituents. Without a live holdings feed or a performance-attribution report, investors are buying into a theme while the data stays in the filing trail stack. (source: SEC EDGAR fund search for CBOT, https://www.sec.gov/edgar/search/#/q=CBOT)
What would deepen the file next: a live index-holdings feed from the issuer, a tracking-error report against the stated benchmark, or a third-party verification of the fund’s stated expense accrual. Until then, CBOT trades on narrative rather than numbers, and the robots remain safely out of the spotlight. (source: SEC EDGAR fund search for CBOT, https://www.sec.gov/edgar/search/#/q=CBOT)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Open an Atlas research path on CBOT
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CBOT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CBOT FAQ
What is Corgi Robots & Humanoids ETF (CBOT)?Corgi Robots & Humanoids ETF (CBOT) has a latest verified close of 25.64, up 2.03%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
Corgi Robots & Humanoids ETF (CBOT) has a latest verified close of 25.64, up 2.03%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CBOT?Corgi Robots & Humanoids ETF (CBOT) has a latest verified close of 25.64, up 2.03%, dated 7 Aug 2026. It brings the latest available chart, company context, cited...
Corgi Robots & Humanoids ETF (CBOT) has a latest verified close of 25.64, up 2.03%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CBOT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CBOT page updated?The CBOT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CBOT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CBOT?The CBOT file starts with Nasdaq Trader and TradingView BATS:CBOT. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CBOT file starts with Nasdaq Trader and TradingView BATS:CBOT. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CBOT?Yes. The workstation can open CBOT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CBOT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CBOT page investment advice?No. The CBOT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CBOT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CBOT
Etf · evidence first